ERGO - EndocRine Guideline Optimisation

ERGO aims to improve hazard assessment of Endocrine Disrupting Chemicals (EDCs) for the protection of human health and the environment by breaking down the wall that currently exists between the different research fields that investigate adverse effects of EDCs in different vertebrate classes, from fish and amphibians (non-mammalian vertebrates) to humans (mammalian vertebrates) by demonstrating that it is feasible to extrapolate effects of EDCs across the vertebrate classes, i.e. an adverse effect observed in a fish or amphibian will also raise concern for an adverse effect in humans.

Short Profile

Duration

01.01.2019
31.12.2024
Department
(Dept. 4) Fish Biology, Fisheries and Aquaculture
Topic
Funded by

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 825753 (ERGO).

Partners

The ERGO consortium brings together 15 partners from eight countries and is coordinated by Syddansk Universitet (SDU). The consortium consists of 10 research bodies, two industry companies, one small to medium enterprise, one environmental protection agency and one consultancy.

Contact person

Werner Kloas

Head of Department
Research group
Aquaponics and Ecophysiology

Share page